Evogene's insect control genes show effectiveness against insects in testing.
Evogene announced that an external laboratory and in-house testing had confirmed that leading Evogene insect control genes demonstrated efficacy against insects with resistance to current commercial insect control products, including fall armyworm and diamondback moth. These results indicate that Evogene has identified new Modes-of-Action for insect control. The genes were identified and predicted by Evogene's in silico CPB platform to provide high insecticidal activity through new MoAs. These genes have previously met efficacy criteria presenting high insecticidal activity, achieving the first milestone and leading to phase advancement. Today's announcement focuses on achieving the second milestone, a new MoA. Currently these genes are going through transformation to corn and soybean with greenhouse results expected in 2019 against relevant major pests.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 27, 2018|
|Previous Article:||Axsome Therapeutics expands loan agreement with Silicon Valley Bank.|
|Next Article:||Rocket Pharmaceuticals receives FDA RMAT, Fast Track designations for RP-L102.|